Shafferman, Avigdor
The Challenge of Highly Pathogenic Microorganisms
1. The Anthrax Capsule: Role in Pathogenesis and Target for Vaccines and Therapeutics
Arthur M. Friedlander
2. Proteomic Studies of
Theodor Chitlaru, Orit Gat, Galia Zaide, Haim Grosfeld, Izhak Inbar, Sharon Ehrlich, Moshe Leitner, Ofer Cohen, Avigdor Shafferman
3. Dynamics of
Pierre L. Goossens, Ian J. Glomski, Lhousseine Touqui, Michèle Mock
4. Survival and Trafficking of
James B. Bliska
5. The Inverse Relationship Between Cytotoxicity of
Emanuelle Mamroud, Avital Tidhar, Yinon Levy, Erez Bar-Haim, Gideon Halperin, Yehuda Flashner, Sara Cohen, Avigdor Shafferman, Ayelet Zauberman
6. The NlpD Lipoprotein of
Avital Tidhar, Yehuda Flashner, Sara Cohen, Yinon Levy, Ayelet Zauberman, David Gur, Moshe Aftalion, Shirley Lazar, Eytan Elhanany, Anat Zvi, Avigdor Shafferman, Emanuelle Mamroud
7. Dissection of the Functions of the IglC Protein of
Jeanette E. Bröms, Moa Lavander, Anders Sjöstedt
8.
Andrey P. Anisimov, Svetlana V. Dentovskaya, Anna N. Kondakova, Buko Lindner, Rima Z. Shaikhutdinova, Nina A. Kocharova, Sof’ya N. Senchenkova, Yuriy A. Knirel
9. The Interactions Between Pathogens and Dendritic Cells: From Paralysis of Cells to Their Recruitment for Bacterial Colonization
Baruch Velan, Erez Bar-Haim, Gal Markel, Hila Cohen, Ayelet Zauberman, Sara Cohen, Avigdor Shafferman
10. Comparative Approaches to Identify Host Factors Specifically Targeted by
Françoise Guinet, Patrick Avé, Louis Jones, Michel Huerre, Elisabeth Carniel
11. Poxvirus Entry into Host Cells
Bernard Moss, Zain Bengali, Himani Bisht, Jason P. Laliberte, P.S. Satheskumar
12. Role of A33R Amino-Acid 118L in the Interactions of Vaccinia Virus with the Host
Nir Paran, Shlomo Lustig, Anat Zvi, Tomer Israely, Sharon Melamed, Noam Erez, Boaz Politi, David Ben-Nathan, Paula Schneider, Batel Lachmi, Ofir Israeli, Dana Stein, Reuven Levin, Udy Olshevsky
13. Inhibitors of Innate Immunity from Vaccinia Virus
Geoffrey L. Smith
14.
Svetlana Bardenstein, Menachem Banai
15. MMP-9 as a Marker for Vaccinia Virus Related Encephalitis
Tomer Israely, Sharon Melamed, Noam Erez, Boaz Politi, Udy Olshevsky, Reuven Levin, Shlomo Lustig, Nir Paran
16. Epidemic Cowpox Virus Infections in Germany
Andreas Kurth, Andreas Nitsche
17. The
Yinon Levy, Anat Zvi, Haim Grosfeld, Avital Tidhar, David Gur, Yehuda Flashner, Eitan Elhanany, Emanuelle Mamroud, Sara Cohen, Avigdor Shafferman
18. Genetic Detection of Vesicle Forming Pathogens by Arrayed Primer Extension (APEX)
Adi Beth-Din, Ofir Israeli, Ohad Shifman, Dana Stein, Einat Ben-Arie, Nir Paran, Shlomo Lustig, Anat Zvi, Naomi Ariel, Arie Ordentlich
19. Subtyping Biothreat Bacterial Pathogens
Paul Keim, Talima Pearson
20. A Rapid Method for
Haim Levy, Morly Fisher, Naomi Ariel, Shay Weiss, Anat Zvi, David Kobiler, Zeev Altboum
21. Tularemia – A Disease with an Uncertain Impact on Public Health
Roland Grunow, Daniela Jacob, Andrea Kühn, Herbert Nattermann
22. Consequences of Antibiotic Treatment of
Erez Bar-Haim, Hila Cohen, Raphael Ber, Ofer Cohen, Avigdor Shafferman
23. Novel Live Vaccine Candidates Against Airborne
Wayne Conlan, Anders Sjöstedt
24. Effect of Disruption of
Ofer Cohen, Galia Zaide, Erez Bar-Haim, Itai Mendelson, Orit Gat, Sharon Ehrlich, Gila Friedman, Avigdor Shafferman
25. Data Mining, Bioinformatic and Immunoinformatic Analyses of
Anat Zvi, Naomi Ariel, Avigdor Shafferman
26. Modified Vaccinia Virus Ankara (MVA) based Vaccines – Immunostimulatory and Protective Capacity
Michael H. Lehmann, Melanie Kremer, Yasemin Suezer, Gerd Sutter
27. Therapeutic Potential of Vaccinia Hyper Immune Sera in Mouse Models of Lethal Orthopoxviruses Infection
Sharon Melamed, Nir Paran, Tomer Israely, Noam Erez, Shaul Reuveny, Arie Ordentlich, Shlomo Lustig
28. A Live Plaque Vaccine Candidate with Improved Safety and Immunogenecity
V.A. Feodorova, L.N. Pan’kina, E.P. Savostina, O.S. Kuznetsov, N.P. Konnov, L.V. Sayapina, S. V. Dentovskaya, R.Z. Shaikhutdinova, S.A. Ageev, B. Lindner, A.N. Kondakova, O. Holst, G.B. Pier, Y.A. Knirel, A.P. Anisimov, V.L. Motin
29. Protection Against Plague Afforded by Treatment with Polyclonal αLcrV and αF1 Antibodies
Yinon Levy, Yehuda Flashner, Ayelet Zauberman, Avital Tidhar, Moshe Aftalion, Shirley Lazar, David Gur, Sara Cohen, Avigdor Shafferman, Emanuelle Mamroud
30. Combination of Anthrax-Toxin Neutralizing Antibodies: Analysis of Synergism/Antagonism Effect
Ohad Mazor, Einat Ben-Arie, Adva Mechaly, Ronit Rosenfeld, Hadar Marcus, Arie Ordentlich
31. The Efficacy of Antibiotic Treatment to Cure Guinea Pigs Intranasally Infected with
Zeev Altboum, Haim Levy, Shay Weiss, Avi Pass, Nili Rothschild, Arnon Tal, Ada Barnea, Josef Schlomovitz, David Kobiler
32. Reverse Vaccinology in
Avigdor Shafferman, Orit Gat, Naomi Ariel, Theodor Chitlaru, Haim Grosfeld, Anat Zvi, Izhak Inbar, Galia Zaide, Ronit Aloni-Grinstein, Sara Cohen
Avainsanat: Biomedicine, Medical Microbiology, Microbiology, Vaccine, Bacteriology, Eukaryotic Microbiology, Microbial Genetics and Genomics
- Tekijä(t)
- Shafferman, Avigdor
- Ordentlich, Arie
- Velan, Baruch
- Julkaisija
- Springer
- Julkaisuvuosi
- 2010
- Kieli
- en
- Painos
- 1
- Sivumäärä
- 18 sivua
- Kategoria
- Terveys, kauneus, muoti
- Tiedostomuoto
- E-kirja
- eISBN (PDF)
- 9789048190546